Intellectual Property India Publishes Patent Application for 'Salt Of S-Oxprenolol' Filed by Actimed Therapeutics Ltd.; and Faraday Pharmaceuticals, Inc.

MUMBAI, India, Aug. 22 -- Intellectual Property India has published a patent application (202517072460 A) filed by Actimed Therapeutics Ltd.; and Faraday Pharmaceuticals, Inc., Ascot, U.K., on July 30, for 'salt of s-oxprenolol.'

Inventor(s) include Joseph, Melissa; Lawrence, Ronnie Maxwell; Morten, Elaine; Chitre, Saurabh; Kelk, Natalie Louise; and Callahan, Craig.

The application for the patent was published on Aug. 22, under issue no. 34/2025.

According to the abstract released by the Intellectual Property India: "The invention relates to a pharmaceutically acceptable acid addition salt of: (i) S- oxprenolol; and (ii) phosphoric acid. Medical uses of the salt and compositions comprising the salt are also described."

The patent application was internationally filed on Jan. 26, 2024, under International application No.PCT/GB2024/050208.

Disclaimer: Curated by HT Syndication.